Curebound has announced eight grants for a total of $2 million in funding. The funding is made available through two new Curebound programs: Catalyst Grants, which support projects within early-stage life science companies that are seeking to take innovative discoveries to commercially approved products, and Equity Grants, which focus on overcoming disparities in cancer research and treatment in underserved populations.
Paradigm Health and Flatiron Health announced that Paradigm Health will acquire Flatiron’s Clinical Research Business, which has built a tech-enabled U.S. oncology research network.
Ben Ho Park and Sara M. Tolaney will receive American Association for Cancer Research awards at the the San Antonio Breast Cancer Symposium Dec. 9-13 for their contributions to breast cancer research. xxx:moreAACR is a c
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s unique healthy breast tissue repository, the Susan G. Komen Tissue Bank, has been awarded a two-year, $750,000 grant from Susan G. Komen.
UPMC Hillman Cancer Center and the University of Pittsburgh have announced the appointment of Kathryn Schmitz and José P. Zevallos as deputy directors of UPMC Hillman Cancer Center. xxx:moreBoth served in inter
NRG Oncology, NCI, and National Clinical Trials Network recently announced changes in leadership across multiple committees.
Jihad Obeid was appointed as assistant vice president for research for AI Strategy & Research Intelligence at the Medical University of South Carolina.
Mark Veich was namedchief organizational advancement officer at the Parker Institute for Cancer Immunotherapy.
Christopher J. Liekweg was namedassociate director for administration and chief department administrator at the University of Michigan Rogel Cancer Center.
Vincent Wu was named a Caspar Wistar Fellow at the Wistar Institute’s Vaccine & Immunotherapy Center.
